Bio-Rad Laboratories (BIO-B) Treasury Shares (2012 - 2026)

Bio-Rad Laboratories (BIO-B) has 15 years of Treasury Shares data on file, last reported at $1.1 billion in Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.1 billion, up 21.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 21.47% YoY), and the FY2025 annual result was $1.0 billion, up 30.76% from the prior year.
• Treasury Shares improved to $1.1 billion in Q1 2026 per BIO-B's latest filing, from $1.0 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $4.1 million in Q2 2025 and troughed at $279544.0 in Q1 2022.
• A 5-year average of $2.0 million and a median of $2.3 million in 2024 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 147.99% in 2022 and fell as far as 29.1% in 2022.
• A 5-year view of Treasury Shares shows it stood at $263.6 million in 2022, then surged by 139.96% to $632.5 million in 2023, then increased by 22.07% to $772.1 million in 2024, then soared by 30.76% to $1.0 billion in 2025, then grew by 4.3% to $1.1 billion in 2026.
• Business Quant data shows BIO-B's Treasury Shares at $1.1 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.